Lifeboat Foundation

Want to fight aging; eat this new chocolate.

Cambridge UK (PRWEB UK) 19 June 2016 Lycotec Ltd., a biotech company based in Cambridge UK, http://www.lycotec.com announces that they have developed the World’s First Longevity SIRT Chocolate, which after ingestion provides a blood level of unmodified trans-Resveratrol, t-RSV, equal to its level after drinking red wine.

T-RSV is the molecule of plant polyphenol class which is typically present in red grapes, some berries, cocoa and nuts. There are a number of beneficial health effects of t-RSV from cardioprotective to antidiabetic. However, one of its intriguing properties is the ability to activate a group of SIRT genes. These genes are responsible for controlling cellular stress protection and longevity.

When t-RSV is consumed as part of food, or a beverage, or as an isolated extract in the form of most supplements, it quickly gets modified and inactivated in the digestive tract. Drinking red wine is the only known exception when t-RSV can reach the blood in an unmodified active form at a detectable level.

Continue reading “World’s First Longevity SIRT Chocolate” »

Facing a long wait for evidence, a longevity researcher takes an unusual path to market.

Crowdfunding Campaign: https://www.lifespan.io/campaigns/the-major-mouse-testing-program/

We are testing a combination of compounds which clear out dysfunctional cells in the body, called Senolytics, to see if we can extend maximum lifespan and healthspan in mice. Please subscribe, share, and fund our Lifespan.io campaign today!

Continue reading “MMTP — Major Mouse Testing Program — Interview with David Gems” »

A feature story in The Guardian on my presidential run to grow the transhumanism movement. Thanks for your support!

Zoltan Istvan leads the Transhumanist party and believes that, through science, humans will reverse ageing and eventually death. Can he convert the skeptics?

I’m 55 years old. I’m shooting for a multihundred-year lifespan. That’s my goal. If you don’t shoot for it, you’re not going to hit it, right?”

I guess he’ll want to speak to George Church.

The author of this titles it “to 150” yet Peter here says multi hundred, and included a pic of Venter who has said he doesn’t think people should live past 120.

Continue reading “How to Live to 150” »

List of the who’s who are leading some of key bio programs around nextgen bio/ living cell technologies.

According to GEN’s experts, synthetic biology isn’t yet plug-and-play, but cellular processes are being engineered into biosensing systems as well as biologics production. Soon, for tasks from theranostics to regenerative medicine, “there will be a synbio app for that.”

USA Today story:

As co-writer for USA TODAY’S “For the Record,” I’ve been writing about the campaigns of Republican, Democratic, Libertarian and Green presidential candidates since the newsletter’s launch last summer. But the first presidential candidate to reach out to me was Zoltan Istvan, the Mill Valley, California-based Transhumanist Party candidate who foresees the merger of humans and technology in the very near future. I spoke by phone with Istvan last week.

Big promises are the hallmark of presidential campaigns.

Continue reading “Zoltan Istvan 2016: Let’s make Americans immortal” »

The new goal is to reverse aging, not only in animals, but in humans. And age reversal is essential, as significant age-related disruption has already occurred in most people due to changes in our gene expression profiles.

Gene expression patterns change with age. This influences the rate at which an individual ages, and also determines what senile disorders they are likely to contract. But innovative gene-editing methods based on a unique technology called CRISPR (clustered regularly interspaced short palindromic repeats) are now being successfully harnessed for use as an age-reversal therapy for humans.

In response to these breakthroughs, Life Extension® magazine sent biogerontologist Dr. Gregory M. Fahy to Harvard University to interview Dr. George Church, who is a leading developer of cutting-edge CRISPR techniques. Here, Dr. Church explains remarkable opportunities for transforming human aging that may begin to unfold sooner than most have imagined.

Continue reading “First phase 1 human aging reversal trials (GDF, Myostatin) in a year or two and George Church discusses how to affordably rejuvenate the whole body” »

Life Extension e InSilico Medicine anunciaram uma esforço colaborativo para identificar romance biomarcadores de envelhecimento humano através do uso de big data analytics e inteligência artificial.